Veterinary Medicines

LINEOMAM LC, Intramammary solution

Authorised
  • Lincomycin
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
LINEOMAM LC 330 mg/10 ml + 100,000 IU/10 ml ενδομαστικό διάλυμα
LINEOMAM LC, Intramammary solution
Active substance:
  • Lincomycin
  • NEOMYCIN SULFATE
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Lincomycin
    330.00
    milligram(s)
    /
    1.00
    Applicator
  • NEOMYCIN SULFATE
    100000.00
    international unit(s)
    /
    1.00
    Applicator
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        3
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Plastic Applicator 24 x 1.0 Applicator

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 72522/28-07-2021/K-0226401
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0138/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."